MKMelissa R. Kaufman

Melissa R. Kaufman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Melissa R. Kaufman has a total of 371 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Understanding the Impact of Rurality: Outcomes for Women With Urinary Incontinence

    by Lan Anh S. Galloway, Janavi Sethurathnam, William Furuyama, Karla Rebullar, Melissa R. Kaufman, Roger R. Dmochowski, Elisabeth M. Sebesta

  • Open Access

    Understanding the Impact of Rurality: Outcomes for Women with Urinary Incontinence

    by Lan Anh Summer Galloway, Janavi Sethurathnam, William Furuyama, Karla Rebullar, Melissa R. Kaufman, Roger R. Dmochowski, Elisabeth Sebesta

    IntroductionUrinary incontinence (UI) affects around 50% of all adult women in the United States. Despite its prevalence and well-documented impact on quality of life (QOL), only the minority of women with UI seek care. Rurality is an established driver of health outcomes across many chronic conditions, yet its specific impact on women with UI remains understudied. MethodsAdult women with any type and severity of UI were recruited from outpatient urology clinics and electronically via ResearchMatch from the surrounding community between December 2022 and May 2023. Participants were asked to complete anonymous questionnaires in REDCap assessing sociodemographics (including zip code to determine rurality), urinary symptoms, unmet social needs, and disease burden. Rural and non-rural participants were compared, and multivariable logistic regression was used to assess associations between individual unmet social needs and rurality.ResultsOf the 1,006 women with UI in our cohort, 15.9% lived in a rural area. Rural women differed significantly in sociodemographics from non-rural women (Table 1). Despite similar UI severity between groups, rural women reported a greater burden of unmet social needs, worse LUTS-specific QOL, and greater financial toxicity and psychosocial burden as compared to non-rural women. ConclusionsIn this cohort of women with UI, rural women face a compounding set of psycho-socio-financial burdens of their urinary symptoms, despite similar UI severity as compared to non-rural women. Effective care for this population requires a multi-disciplinary approach beyond the clinic by integrating telehealth, social work, financial counseling, and community-based resources into management of UI.

  • Open Access

    One‐Year Functional Satisfaction and Quality of Life Outcomes of Patients With a History of Radiotherapy With Artificial Urinary Sphincters

    by Vishu Chandrasekhar, Melissa R. Kaufman, Andrew C. Peterson, Erin L. Chaussee, Hadley M. Wood

    Aims: This study assessed how functional satisfaction and quality of life outcomes of the artificial urinary sphincter (AUS) were affected in patients who received radiation for prostate cancer. Methods: A secondary analysis was conducted based on the Artificial Urinary Sphincter Clinical Outcomes (AUSCO) study, a prospective multi‐institutional study. Baseline characteristics, safety event rates, pad weight reduction rates, and quality of life (QOL) outcomes based on questionnaires were compared between a cohort of radiated and non‐radiated patients. Results: Twenty‐five subjects were identified for the cohort of radiated patients. When looking at incontinence outcomes such as urge incontinence and stress incontinence events as well as pad weight reduction goals, no differences were seen between the radiated and nonradiated cohorts. Patient perception of incontinence and QOL were also not significantly different between the two cohorts. Demographic factors, adverse events, and device deficiency rates showed no significant differences as well. Conclusions: Our study showed no difference in incontinence or QOL outcomes in AUS patients with a history of radiation therapy for prostate cancer compared to those who did not receive radiation at 1 year. Further studies are necessary to identify whether radiation therapy impacts incontinence or QOL in the long term, as well as to examine whether different patient populations experience different outcomes. Trial Registration: National Clinical Trial (NCT) Identified Number: NCT04088331.

  • Top Cited Papers
    Open Access

    The Artificial Urinary Sphincter Clinical Outcomes Trial: Primary Results

    by Melissa R. Kaufman, Hadley M. Wood, Ryan Terlecki, Daniel Moon, Jeremy Myers, Alex J. Vanni, LeRoy Jones, Joshua A. Broghammer, Gerard Henry, Benjamin N. Breyer, et al.

    The artificial urinary sphincter endures as the standard of care treatment for mild to severe male stress urinary incontinence. Prior studies report outcomes from predominantly single-center retrospective series. Herein we present data from a multi-institutional analysis of artificial urinary sphincter outcomes (AUSCO) to assess efficacy, safety, and quality of life to standardize result reporting. AUSCO is a single-arm, prospective, multi-center study designed to evaluate the AMS 800™ in men with primary stress urinary incontinence (NCT04088331). One hundred fifteen participants were implanted at 17 sites. The primary endpoint was > 50% improvement in 24-hour pad weight 12 months post device activation. Secondary endpoints including pad use, urinary incontinence events per day, quality of life and device satisfaction were measured between 3- and 12- months post device activation and compared to baseline. At 12 months, 94% (91/97) participants experienced >50% pad weight reduction (p<0.001) and 60% (61/101) reported zero pad use. Participants also reported substantial improvement in quality of life scores and incontinence events per day post device activation. Seventeen participants (15%) had serious adverse events, 10 (8.7%) in which the events were device related. Nine participants (7.8%) had revisions: mechanical malfunction (3), erosion (2), lack of efficacy (1), other (3), and zero due to infection. In this prospective trial, the artificial urinary sphincter allowed most men to achieve total continence with a serious adverse event rate less than 15%. Participants experienced significant continence recovery with transformational improvement in patient-reported outcomes.


  • Botulinum Toxin Injection

    by Melissa R. Kaufman, Elizabeth A. Rourke

  • Open Access

    The Artificial Urinary Sphincter Improves Emotional Health in Men With Stress Urinary Incontinence: Results From the Prospective, Multi-institutional AUSCO Study

    by Andrew C. Peterson, Hadley M. Wood, Jeremy Myers, Benjamin N. Breyer, Bradley A. Erickson, Thomas G. Smith Iii, Erin L. Chaussee, Melissa R. Kaufman, Ryan Terlecki, Niels V. Johnsen, et al.


  • Artificial Urinary Sphincter Pressure-Regulating Balloon: Complications Management

    by Delaney J. Orcutt, Karla R. Rebullar, Melissa R. Kaufman, Niels V. Johnsen

  • Top Cited Papers

    The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause

    by Melissa R. Kaufman, A. Lenore Ackerman, Katherine A. Amin, Marge Coffey, Elisheva Danan, Stephanie S. Faubion, Anne Hardart, Irwin Goldstein, Giulia M. Ippolito, Gina M. Northington, et al.

    Genitourinary syndrome of menopause (GSM) describes the symptoms and physical changes that result from declining estrogen and androgen concentrations in the genitourinary tract during the menopausal transition. There has not been a consensus reached about the number or type of symptoms needed to diagnose GSM, and the associated urinary symptoms are also linked with other common urologic conditions (e.g., overactive bladder) in older patients. This guideline provides information to clinicians regarding identification, diagnosis, counseling, and treatment for patients with GSM to optimize symptom control and quality of life while minimizing adverse events (AEs). The systematic review utilized in the creation of this guideline is based on research conducted by the Minnesota Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ) and funded by the Patient Centered Outcomes Research Institute (PCORI). The EPC extracted and synthesized effectiveness and/or harms outcomes from 68 publications. An additional 66 publications evaluating 46 non-hormonal interventions, were described in an evidence map. Clinicians diagnose GSM based on symptoms, with or without related physical findings, and after ruling out other etiologies or co-occurring pathologies. There is a large body of evidence examining the use of hormonal and non-hormonal treatment options to manage the symptoms of GSM; however, the local low-dose vaginal estrogen has the most robust evidence base. The strategies defined in this document were derived from evidence-based and consensus-based processes. Given that there is insufficient information to recommend one hormonal therapy over another, this guideline is not meant to support a stepwise progression through different hormonal approaches. The clinician should make treatment decisions in the context of shared decision-making considering patient goals and preferences, using the evidence of efficacy and AEs of each possible intervention as a guide.


  • Open Access

    Toileting and Bladder Health in the Gig Economy

    by Leah Chisholm, Andria N. Li, Parisa Samimi, Melissa R. Kaufman, Roger R. Dmochowski, William Stuart Reynolds, Elisabeth M. Sebesta

    Objective: An increasing percentage of the population participates in the “gig economy” – short‐term work through online applications. This study often requires continuous travel without reliable restroom access. We aimed to assess toileting behaviors and bladder health in gig economy workers.Methods: Adult gig workers were electronically recruited using ResearchMatch. Participants completed validated questionnaires assessing bladder health, lower urinary tract symptoms (LUTS), toileting behaviors, and information about gig economy work. Toileting behaviors, coping strategies, and aspects of their work were compared between those with and without difficulty finding restrooms while at work.Results: Of 527 gig workers who participated, 80 (15%) reported difficulty finding restrooms while working. Demographics and type of gig work were similar between groups. Gig workers with difficulty finding restrooms reported higher rates of unhealthy toileting behaviors and coping strategies, such as fluid restricting and delayed voiding. While at work, those with difficulty finding restrooms experienced more severe LUTS. While difficulty finding restrooms was not associated with any psychosocial or demographic factors, it was associated with worsening of urinary symptoms since starting gig work.Conclusions: Gig workers overall report engaging in unhealthy toileting behaviors and coping strategies at work. Gig workers with difficulties in accessing restrooms while working report higher severity of irritative LUTS and are more likely to demonstrate poor toileting habits, which may further exacerbate underlying bladder conditions. Further research is needed to better understand the long‐term associations between bladder health, restroom access and employment in the gig economy.Clinical Trial Registration: This study does not require clinical trial registration as no randomized clinic trial was performed.